The prophylaxis of gonorrhea.
The current level of the gonorrhea epidemic supports the need for additional measures for gonorrhea control. In the absence of evidence that prophylactic availability enhances promiscuity, a strong case can be made for venereal disease prophylaxis. This paper reviews the efficacy and acceptability of prophylactic techniques. In the military, acceptability and efficacy have been demonstrated for systemic antibiotics, and probably a postcoital prophylactic kit. These measures are either inappropriate or unavailable for general civilian use. The condom and vaginal spermicides offer promise of partial protection; further studies of efficacy and utilization are needed.
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D000985:Antisepsis; D003075:Coitus; D003270:Contraceptive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003274:Contraceptive Devices, Female; D003275:Contraceptive Devices, Male; D003280:Contraceptives, Oral, Synthetic / Q000627:therapeutic use; D005260:Female; D006069:Gonorrhea / Q000517:prevention & control*; D006801:Humans; D007434:Intrauterine Devices; D007463:Iodobenzoates / Q000627:therapeutic use; D008297:Male; D009824:Ointments; D012836:Silver Proteins / Q000627:therapeutic use; D013432:Sulfathiazoles / Q000627:therapeutic use; D007507:Therapeutic Irrigation; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D003270:Contraceptive Agents; D003280:Contraceptives, Oral, Synthetic; D007463:Iodobenzoates; D009824:Ointments; D012836:Silver Proteins; D013432:Sulfathiazoles